Cargando…
Distribution of Peripheral Blood Cells in Esophageal Cancer Patients During Concurrent Chemoradiotherapy Predicts Long-Term Locoregional Progression Hazard After Treatment (GASTO1072)
PURPOSE: Predicting the response to chemoradiotherapy is critical for the optimal management of esophageal cancer; however, it remains an unmet clinical need. This study aimed to evaluate the predictive potential of peri-treatment peripheral blood cells (PBC) in disease progression hazard in esophag...
Autores principales: | Xu, Liangyu, Chen, Jianzhou, Guo, Hong, Huang, Ruihong, Guo, Longjia, Yu, Yuanxiang, Zhai, Tiantian, Wu, Fangcai, Chen, Zhijian, Li, Derui, Chen, Chuangzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164679/ https://www.ncbi.nlm.nih.gov/pubmed/34079373 http://dx.doi.org/10.2147/CMAR.S307695 |
Ejemplares similares
-
A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072)
por: Liu, Weitong, et al.
Publicado: (2022) -
Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal Carcinoma
por: Huang, Ruihong, et al.
Publicado: (2020) -
Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy
por: Zeng, Chengbing, et al.
Publicado: (2021) -
Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study
por: Chen, Jianzhou, et al.
Publicado: (2016) -
Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study
por: Chen, Chuangzhen, et al.
Publicado: (2021)